+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Narcolepsy Treatment Market by Drug Class, Disorder Type, Age Group, Distribution Channel - Global Forecast to 2030- Product Image
Narcolepsy Treatment Market by Drug Class, Disorder Type, Age Group, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Narcolepsy Treatment Market by Drug Class, Disorder Type, Age Group, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968747
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The narcolepsy treatment market is experiencing significant momentum, fueled by therapeutic innovation, rising clinical awareness, and expanding access models. As decision-makers seek clarity on both current opportunities and strategic risks, targeted analysis is critical for effective positioning in this dynamic space.

Market Snapshot: Narcolepsy Treatment Market

The Narcolepsy Treatment Market grew from USD 2.14 billion in 2024 to USD 2.31 billion in 2025. It is expected to continue growing at a CAGR of 7.86%, reaching USD 3.38 billion by 2030. Market expansion is driven by advancements in orexin research, diversification of therapeutic agents, and greater cross-sector collaboration. As this environment evolves, the rapid adoption of digital health solutions and shifts in reimbursement frameworks are influencing both product lifecycle management and patient access.

Scope & Segmentation

This report provides a comprehensive examination of the market’s breadth across segments, technology advances, and regional performance:

  • Drug Classes: Antidepressants, orexin receptor agonists, sodium oxybate, stimulants
  • Disorder Types: Narcolepsy Type 1, Narcolepsy Type 2
  • Age Groups: Adults, geriatrics, pediatrics
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Geographic Coverage: Americas (USA, Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Industry Players: AstraZeneca plc, Avadel Pharmaceuticals, Bayer AG, Boehringer Ingelheim GmbH, Cipla Limited, Eli Lilly and Company, Glenmark Pharmaceuticals Limited, Indivior plc, Jazz Pharmaceuticals plc, Johnson & Johnson Services, Inc., Lannett Company, Inc., Lupin Limited, Merck & Co., Inc., Mylan N.V. by Viartis, NLS Pharmaceutics, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited
  • Technology Integration: Adoption of digital health platforms, telemedicine, wearable monitoring devices, and data analytics

Narcolepsy Treatment Market: Key Takeaways

  • The product landscape is evolving, with orexin receptor agonists providing new options beyond traditional stimulant-based approaches.
  • Digital health tools—by supporting remote diagnosis, symptom monitoring, and patient engagement—are redefining care delivery and improving adherence.
  • Personalized medicine initiatives are leveraging genetic and phenotypic insights to target therapies to subgroups, with increasing use of real-world evidence guiding payer decision-making.
  • Value-based reimbursement models now drive evidence generation by manufacturers, spurring collection of robust long-term effectiveness data to support product positioning.
  • Regional market performance varies by healthcare infrastructure: North America adopts innovative therapies quickly, while Asia-Pacific is shaped by regulatory improvements and the EMEA region is marked by uneven access and reimbursement conditions.
  • Collaborative partnerships across pharmaceutical, clinical, and patient advocacy stakeholders are accelerating the pace of research, regulatory submissions, and market entry for novel therapies.

Tariff Impact and Supply Chain Dynamics

Recent increases in US import tariffs have introduced complexity to the procurement and distribution of both active pharmaceutical ingredients and finished narcolepsy treatments. Manufacturers are experiencing increased raw material costs, prompting supply chain recalibration and closer attention to nearshoring opportunities. Health systems are responding with adjusted procurement strategies and, in some cases, expanded cost-sharing initiatives to sustain therapy access for patients.

Methodology & Data Sources

This report applies a rigorous methodology, incorporating secondary research from peer-reviewed journals, regulatory filings, and conference proceedings, complemented by primary interviews with clinicians, executives, and advocacy representatives. Triangulated data and expert panel validation underpin the analytical framework, ensuring relevant and actionable insights for market participants.

Why This Report Matters

  • Enables leaders to align investments with emerging patient needs, technology trends, and payer priorities by providing detailed segmentation and actionable qualitative insights.
  • Supports strategic planning by clarifying the compounded impact of policy changes, supply chain disruptions, and evolving distribution models.

Conclusion

As the narcolepsy treatment market rapidly evolves, stakeholders who prioritize agility, evidence-driven strategies, and multi-sector collaboration will be best positioned to realize growth and deliver value to patients and partners.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Narcolepsy Treatment Market, by Drug Class
8.1. Introduction
8.2. Antidepressants
8.3. Orexin Receptor Agonists
8.4. Sodium Oxybate
8.5. Stimulants
9. Narcolepsy Treatment Market, by Disorder Type
9.1. Introduction
9.2. Narcolepsy Type 1
9.3. Narcolepsy Type 2
10. Narcolepsy Treatment Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Geriatrics
10.4. Pediatrics
11. Narcolepsy Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Narcolepsy Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Narcolepsy Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Narcolepsy Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AstraZeneca plc
15.3.2. Avadel Pharmaceuticals
15.3.3. Bayer AG
15.3.4. Boehringer Ingelheim GmbH
15.3.5. Cipla Limited
15.3.6. Eli Lilly and Company
15.3.7. Glenmark Pharmaceuticals Limited
15.3.8. Indivior plc
15.3.9. Jazz Pharmaceuticals plc
15.3.10. Johnson & Johnson Services, Inc.
15.3.11. Lannett Company, Inc.
15.3.12. Lupin Limited
15.3.13. Merck & Co., Inc.
15.3.14. Mylan N.V. by Viartis
15.3.15. NLS Pharmaceutics
15.3.16. Novartis AG
15.3.17. Pfizer Inc.
15.3.18. Sun Pharmaceutical Industries Ltd.
15.3.19. Takeda Pharmaceutical Company Limited
15.3.20. Teva Pharmaceutical Industries Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NARCOLEPSY TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. NARCOLEPSY TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. NARCOLEPSY TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NARCOLEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY OREXIN RECEPTOR AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 33. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 35. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 37. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 39. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 58. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 59. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 62. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 63. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 64. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 67. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 71. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 74. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 75. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 78. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 90. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 91. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 95. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 99. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 102. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 103. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 104. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 107. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 108. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 114. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 119. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 127. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 128. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 130. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 131. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 142. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 143. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 144. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 148. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 151. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 152. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 167. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 168. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
TABLE 191. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Narcolepsy Treatment market report include:
  • AstraZeneca plc
  • Avadel Pharmaceuticals
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cipla Limited
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals Limited
  • Indivior plc
  • Jazz Pharmaceuticals plc
  • Johnson & Johnson Services, Inc.
  • Lannett Company, Inc.
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V. by Viartis
  • NLS Pharmaceutics
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Limited

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.31 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.38 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Narcolepsy Drugs Market by Drug Class, Distribution Channel, Formulation, End User - Global Forecast to 2030 - Product Image

Narcolepsy Drugs Market by Drug Class, Distribution Channel, Formulation, End User - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Narcolepsy Drugs Market Report and Forecast 2024-2032 - Product Image

Narcolepsy Drugs Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033 - Product Image

Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report 2025 - Product Image

Narcolepsy Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Narcolepsy Drug Market

The Narcolepsy Drug market is a subset of the Central Nervous System Drugs market. Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and sudden, uncontrollable episodes of sleep. Narcolepsy drugs are used to reduce the symptoms of the disorder, such as excessive daytime sleepiness, cataplexy, and sleep paralysis. These drugs are typically stimulants, such as modafinil, armodafinil, and methylphenidate. Other drugs used to treat narcolepsy include tricyclic antidepressants, sodium oxybate, and clonidine. Some companies in the Narcolepsy Drug market include Cephalon, Inc., Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.